Ironwood Pharmaceuticals (IRWD) Reports Q4 Loss, Lags Revenue Estimates Ironwood (IRWD) delivered earnings and revenue surprises of -150.00% and -9.62%, respectively, for the quarter ended December 2025. Do the…
Ironwood Pharmaceuticals: Starker Umsatzausblick 2026 lenkt den Fokus zurück auf Linzess! Zum Jahresbeginn verbucht die Aktie von Ironwood Pharmaceuticals einen deutlichen Kursanstieg. Der Grund: Ironwood Pharmaceuticals hat einen überraschend hohen Umsatzausblick für…
Ironwood Pharmaceuticals stock soars on strong 2026 guidance By Investing.com Ironwood Pharmaceuticals stock soars on strong 2026 guidance…
Ironwood Pharmaceuticals stock surges after FDA approval for pediatric IBS-C drug By Investing.com Ironwood Pharmaceuticals stock surges after FDA approval for pediatric IBS-C drug…
Ironwood Pharmaceuticals stock falls as it exits S&P SmallCap 600 By Investing.com Ironwood Pharmaceuticals stock falls as it exits S&P SmallCap 600…
Ironwood Pharmaceuticals shares surge on competitors woes By Investing.com Ironwood Pharmaceuticals shares surge on competitors woes…
Earnings call: Ironwood Pharmaceuticals reports robust Q1 growth By Investing.com Earnings call: Ironwood Pharmaceuticals reports robust Q1 growth…